openPR Logo
Press release

Ovarian Cancer - Heat Map and Analysis

02-27-2017 02:35 PM CET | Health & Medicine

Press release from: Ovarian Cancer

Albany, NY, Feb 27, 2017: Ovarian Cancer (OC) is the fifth most common malignancy diagnosed in women, and the most common gynecological cancer, with an estimated 225,000 new cases diagnosed globally in 2008. Rates are particularly high in developed countries, and especially in Northern Europe. However, substantial improvements in the treatment of OC have been made in recent decades, through the introduction of platinum-based compounds, and improvements in surgery.

This has resulted in an increase in the percentage of patients that survive for five years, from approximately 20% in the 1970s, to the current rate of 45%. However, there have been no significant improvements in the treatment of the disease in recent years, with platinum-based compounds remaining the standard of care for firstand usually second-line treatment.

The differences between many of these products are relatively nuanced, and must be understood fully by companies seeking to position a novel drug in this market. This tabular heatmap framework, designed to provide an easily digestible summary of these clinical characteristics, provides detailed information on all late-stage clinical trial results for products in the OC market and late-stage pipeline. These are split along therapy lines, and are therefore reflective of the treatment algorithm.

Get a Sample Research PDF with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=915795

All safety and efficacy endpoints reported in these trials are displayed, for both the drug and comparison groups. In addition, key study characteristics such as the size, composition and patient segment of the study population are provided. These results are presented in a visually accessible, color-coded manner in order to maximize ease of use.

The accompanying text provides a detailed analysis of the clinical benchmarks set by the current market landscape, and the anticipated changes to these benchmarks, and to the treatment algorithm, as a result of the late-stage pipeline.

Scope

- What are the clinical characteristics of currently approved therapies for OC, in terms of specific safety and efficacy parameters?
- What are the key unmet needs in this indication, and which clinical safety and efficacy parameters are the most closely linked to them?
- What types of therapy are in development and what modes of action do they employ?
- What impact will pipeline products have on the first-line, maintenance and recurrent disease market segments?

Reasons to buy:-

- Understand the current clinical landscape by considering the treatment options available for each patient segment.
- Visually compare the currently approved treatments available at each line of therapy, based on the most important efficacy and safety parameters tested in clinical trials.
- Assess the current late-stage pipeline, in terms of the likely positioning of each product and the implications for the clinical landscape at each line of therapy.
- Build up a nuanced understanding of the clinical benchmarks set by these products, and consider how the current late-stage pipeline will affect these benchmarks.
- Assess your own pipeline programs in light of these benchmarks, in order to optimally position them and maximize uptake by clinicians.

Enquiry at: http://www.researchmoz.us/enquiry.php?type=E&repid=915795

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ovarian Cancer - Heat Map and Analysis here

News-ID: 450419 • Views: 208

More Releases from Ovarian Cancer

Ovarian Cancer - Identifying and Commercializing First-in-Class Innovation: Fron …
Researchmoz added Most up-to-date research on "Ovarian Cancer - Identifying and Commercializing First-in-Class Innovation: Frontier Pharma" to its huge collection of research reports. Ovarian cancer is the sixth most common cancer in females and it also has the highest mortality rate of gynecological cancers. The five-year survival rate is approximately 45%, although the disease is ultimately fatal in the majority of patients due to a high rate of recurrence. Surgery is
Ovarian Cancer - US Market Insights, Epidemiology and Market Forecast-2020
ALBANY, NY, April 6, 2017 : DelveInsights Ovarian Cancer - Market Insights, Epidemiology and Market Forecast-2020- US Reports provides an overview of the disease and global market size of the Ovarian Cancer for the United States. It also includes global historical and forecasted epidemiological data for the diagnosed incident cases of Ovarian Cancer from 2012-2020. According to DelveInsight, the forecasted patient population of Ovarian cancer will decrease at a CAGR
Recent Study on Ovarian Cancer Identifying and Commercializing First-in-Class In …
Researchmoz added Most up-to-date research on "Frontier Pharma: Ovarian Cancer - Identifying and Commercializing First-in-Class Innovation" to its huge collection of research reports. Ovarian cancer is the sixth most common cancer in females and it also has the highest mortality rate of gynecological cancers. The five-year survival rate is approximately 45%, although the disease is ultimately fatal in the majority of patients due to a high rate of recurrence. Surgery is
Therapeutics Development For Ovarian Cancer - Pipeline Insights, 2017
Researchmoz added Most up-to-date research on "Therapeutics Development For Ovarian Cancer - Pipeline Insights, 2017" to its huge collection of research reports. DelveInsights, Ovarian Cancer -Pipeline Insights, 2016, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under the category of Ovarian Cancer. Ovarian cancer is the sudden growth of the cells

All 5 Releases


More Releases for Albany

Global Outbuildings Market 2018 - Suncast, Palram, Albany, OLT
Apex Market Reports, recently published a detailed market research study focused on the “Outbuildings Market” across the global, regional and country level. The report provides 360° analysis of “Outbuildings Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Outbuildings on the basis of
Albany, NY
Tea is the most consumed beverage worldwide next to water. There have been various shifts in the history of tea culture in the United States. Recently, a research report “Tea and RTD Tea - US Market Research Reports - August 2017” has been added to Market Research hub (MRH)’s database. According to the report, tea and RTD market has grown by 24% between 2012-2017. The report also provides an insight into
Food Pail Global Market 2017 by Manufacturers - Aaron Packaging, Albany Packagin …
Global Food Pail Market 2017, presents a professional and in-depth study on the current state of the Food Pail market globally, providing basic overview of Food Pail market including Definitions, Classifications, Applications and Industry chain structure, Food Pail Market report provides development policies and plans are discussed as well as manufacturing processes and cost structures. Food Pail market size, share and end users are analyzed as well as segment markets
Know More About Visit Albany GA Attractions, Hotels and Restaurants
Date: November 24, 2016 Location:112 North Front Street, Albany, GA 31701 Contact Number: 229-317-4760 Email: info@visitalbanyga.com Websites: http://visitalbanyga.com Albany is the city in Georgia and is in close proximity to Columbus, Savannah and Atlanta. The city is rich in heritage, culture, natural beauty and also theatre. Whether it is having breakfast with cheetahs out in their habitat or watching a play or predicting the climate conditions of the city in the weather center, this place
Enjoy Delicious Food at Albany GA Restaurants
Date :- 27 to 28 October, 2016 Location :- 112 North front street, Albany, Ga 31701 Contact No. :- 229-317-4760 Website:- http://visitalbanyga.com Email :- info@visitalbanyga.com Located in the southern Georgia the Albany is a small town along with the big personality. Their boasting as music legend Ray Charles as this one of the sons and tree-lined streets or historic buildings can provide by backdrop for that classic Southern dishes as well as soulful for southern
Know Everything You Need to About Albany GA Attractions
Date : 31 August 2016 Location : 112 North Front Street Albany, GA 31701 Contact Number : 229-317-4760 Toll-Free : 866-750-0840 Email : info@visitalbanyga.com Web Site : http://visitalbanyga.com Albany is one of the cities of Georgia and is prominent because of its cultural importance. It is an interesting place to visit and view some of the best architectural designs from the history including modern Empire State Plaza. It is the longest chartered city in the United States.